Alzheimer Disease Clinical Trials

Phase	Trials	Distribution
Phase 2	7	35%
N/A	7	35%
Phase 1	6	30%

Phase

Trials

Distribution

Phase 2

35%

N/A

35%

Phase 1

30%

Epileptic Hippocampus in Alzheimer's Disease

NCT05899764 · NOT YET RECRUITING · Phase 2

A Phase I, Randomized, Double-Blind Study to Evaluate Safety and Tolerability of Amyloid-β Vaccine, AV-1959D, in Patients With Early Alzheimer's Disease.

NCT05642429 · ACTIVE NOT RECRUITING · Phase 1

Frequently Asked Questions

What clinical trials are available for Alzheimer Disease?

There are 20 clinical trials listed for Alzheimer Disease. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Alzheimer Disease trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Alzheimer Disease trials in?

Current Alzheimer Disease trials are distributed across: Phase 2 (7), N/A (7), Phase 1 (6).

Pipeline by Phase

Trial Status Breakdown

Trials for Alzheimer Disease

Probiotic Supplementation Safety and Feasibility Study in Preclinical Alzheimer's Disease

Reactions to Learning Amyloid and Tau Results in Adults at Risk for Alzheimer's Dementia

Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease - A Global, Prospective, Early Feasibility Study in Alzheimer's Patients

Allogeneic Intraveinous Injection of Adipose Tissue Derived-mesenchymal Stem Cells in Mild to Moderate Alzheimer Disease: a Phase I/II Trial

Blood Biomarkers for Early and Accurate Diagnosis of Alzheimer's Disease in Primary Care

Epileptic Hippocampus in Alzheimer's Disease

A Phase 1b Extension Trial To Allow Repeat Intracerebroventricular Injections of Ex Vivo Expanded, Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Subjects Previously Treated in RBI Protocol RB-ADSC-02

SIPO1-AD: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Siponimod in Patients With Mild Alzheimer's Disease

Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER): a Multicenter, Observational, 3-arms, Prospective Study

Improving Primary Care Clinician's Advance Care Planning Alzheimer's Disease and Related Dementias

A Phase 2, Open Label, Study of AMDX-2011P as a Retinal Tracer in Participants With Alzheimer's Disease

Georgia Memory Net Center for Medicare and Medicaid Services Registry for Anti-Amyloid Monoclonal Antibody Coverage With Evidence Development

A Phase 1b Study to Assess the Safety, Tolerability, and Pharmacokinetics of ION269 in Adults With Down Syndrome (Hero Study)

A Randomized, Participant & Investigator Blinded, Placebo-Controlled Study to Evaluate the Ability of Intrathecally Administered NIO752 to Lower CSF Total Tau Synthesis in Participants With AD Measured by Stable Isotope Labelling Kinetics

A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Immunogenicity of AV-1959R in Healthy Participants

The Effect of Dexmedetomidine on Glymphatic Function in the Human Brain

CLarifying ABCB1's Role in Amyloid Efflux and Alzheimer's Disease Risk

Testing Whether Choline Normalizes Lipid Metabolism in APOE4 Carriers

A Phase I, Randomized, Double-Blind Study to Evaluate Safety and Tolerability of Amyloid-β Vaccine, AV-1959D, in Patients With Early Alzheimer's Disease.

An Open Label Extension of XPro1595 in Patients With Alzheimer's Disease That Have Completed a Phase 1 or Phase 2 Study With XPro1595

Frequently Asked Questions

Find More Trials